These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Chronic ghrelin administration restores hippocampal long-term potentiation and ameliorates memory impairment in rat model of Alzheimer's disease. Eslami M, Sadeghi B, Goshadrou F. Hippocampus; 2018 Oct 15; 28(10):724-734. PubMed ID: 30009391 [Abstract] [Full Text] [Related]
27. The cell-permeable Aβ1-6A2VTAT(D) peptide reverts synaptopathy induced by Aβ1-42wt. Cimini S, Sclip A, Mancini S, Colombo L, Messa M, Cagnotto A, Di Fede G, Tagliavini F, Salmona M, Borsello T. Neurobiol Dis; 2016 May 15; 89():101-11. PubMed ID: 26721320 [Abstract] [Full Text] [Related]
28. Rosiglitazone prevents amyloid-β oligomer-induced impairment of synapse formation and plasticity via increasing dendrite and spine mitochondrial number. Xu S, Liu G, Bao X, Wu J, Li S, Zheng B, Anwyl R, Wang Q. J Alzheimers Dis; 2014 May 15; 39(2):239-51. PubMed ID: 24150104 [Abstract] [Full Text] [Related]
30. Cognitive recovery by chronic activation of the large-conductance calcium-activated potassium channel in a mouse model of Alzheimer's disease. Wang L, Kang H, Li Y, Shui Y, Yamamoto R, Sugai T, Kato N. Neuropharmacology; 2015 May 15; 92():8-15. PubMed ID: 25577958 [Abstract] [Full Text] [Related]
32. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior. Sharma S, Verma S, Kapoor M, Saini A, Nehru B. Neurol Res; 2016 Sep 15; 38(9):838-50. PubMed ID: 27431920 [Abstract] [Full Text] [Related]
33. Val8-glucagon-like peptide-1 protects against Aβ1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats. Wang XH, Li L, Hölscher C, Pan YF, Chen XR, Qi JS. Neuroscience; 2010 Nov 10; 170(4):1239-48. PubMed ID: 20727946 [Abstract] [Full Text] [Related]
34. Involvement of GluN2B subunit containing N-methyl-d-aspartate (NMDA) receptors in mediating the acute and chronic synaptotoxic effects of oligomeric amyloid-beta (Aβ) in murine models of Alzheimer's disease (AD). Rammes G, Mattusch C, Wulff M, Seeser F, Kreuzer M, Zhu K, Deussing JM, Herms J, Parsons CG. Neuropharmacology; 2017 Sep 01; 123():100-115. PubMed ID: 28174113 [Abstract] [Full Text] [Related]
35. Exendin-4 antagonizes Aβ1-42-induced suppression of long-term potentiation by regulating intracellular calcium homeostasis in rat hippocampal neurons. Wang X, Wang L, Jiang R, Yuan Y, Yu Q, Li Y. Brain Res; 2015 Nov 19; 1627():101-8. PubMed ID: 26390937 [Abstract] [Full Text] [Related]
36. Resveratrol ameliorates spatial learning memory impairment induced by Aβ1-42 in rats. Wang R, Zhang Y, Li J, Zhang C. Neuroscience; 2017 Mar 06; 344():39-47. PubMed ID: 27600946 [Abstract] [Full Text] [Related]
37. Cannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer's Disease. Hughes B, Herron CE. Neurochem Res; 2019 Mar 06; 44(3):703-713. PubMed ID: 29574668 [Abstract] [Full Text] [Related]
38. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo. Jing W, Guo F, Cheng L, Zhang JF, Qi JS. Neurosci Lett; 2009 Feb 06; 450(3):306-10. PubMed ID: 19059464 [Abstract] [Full Text] [Related]